Plasmacytoid dendritic cells drive acute asthma exacerbations

Journal of Allergy and Clinical Immunology

Volumn 142, Issue 2, 2018, Pages 542-556.e12

  Chairakaki, Aikaterini Dimitra ^a   Saridaki, Maria Ioanna ^a   Pyrillou, Katerina ^a   Mouratis, Marios Angelos ^a   Koltsida, Ourania ^a,b   Walton, Ross P ^c   Bartlett, Nathan W ^c,d   Stavropoulos, Athanasios ^a   Boon, Louis ^e   Rovina, Nikoletta ^b   Papadopoulos, Nikolaos G ^f,g   Johnston, Sebastian L ^c   Andreakos, Evangelos ^a  

^a BIOMEDICAL RESEARCH FOUNDATION   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^d HUNTER MEDICAL RESEARCH INSTITUTE   (Australia)

^e BIOCEROS   (Netherlands)

^f UNIVERSITY OF MANCHESTER   (United Kingdom)

^g UNIVERSITY OF ATHENS   (Greece)

Author keywords

animal models of allergic airway disease; asthma; asthma exacerbations; Plasmacytoid dendritic cells; rhinovirus

Indexed keywords

ALPHA INTERFERON; CHEMOKINE RECEPTOR CCR7; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 25; INTERLEUKIN 33; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; OX40 LIGAND; THYMIC STROMAL LYMPHOPOIETIN; D17WSU104E PROTEIN, MOUSE; INTERLEUKIN DERIVATIVE;

ADULT; AGED; ALLERGIC AIRWAY INFLAMMATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTHMA; CELL MIGRATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE EXACERBATION; DISEASE SEVERITY; EXPERIMENTAL ASTHMA; GENETIC BACKGROUND; HOSPITALIZATION; HUMAN; IN VIVO STUDY; INFECTION RISK; LUNG RESISTANCE; MEDIASTINUM LYMPH NODE; MOUSE; NONHUMAN; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; RHINOVIRUS INFECTION; UPREGULATION; ACUTE DISEASE; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; CELL CULTURE; CELL MOTION; COMPLICATION; DENDRITIC CELL; DISEASE MODEL; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; PHYSIOLOGY; PICORNAVIRUS INFECTION; RESPIRATORY TRACT ALLERGY; RHINOVIRUS; TH2 CELL;

ACUTE DISEASE; ANIMALS; ASTHMA; CELL MOVEMENT; CELLS, CULTURED; DENDRITIC CELLS; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; HUMANS; INTERLEUKINS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; PICORNAVIRIDAE INFECTIONS; RESPIRATORY HYPERSENSITIVITY; RHINOVIRUS; TH2 CELLS;

EID: 85036525983     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2017.08.032     Document Type: Article

References (56)

1. Masoli, M., Fabian, D., Holt, S., Beasley, R., Global Initiative for Asthma P. The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy 59 (2004), 469–478.
2. Jackson, D.J., Sykes, A., Mallia, P., Johnston, S.L., Asthma exacerbations: origin, effect, and prevention. J Allergy Clin Immunol 128 (2011), 1165–1174.
3. Papadopoulos, N.G., Xepapadaki, P., Mallia, P., Brusselle, G., Watelet, J.B., Xatzipsalti, M., et al. Mechanisms of virus-induced asthma exacerbations: state-of-the-art. A GA2LEN and InterAirways document. Allergy 62 (2007), 457–470.
4. Edwards, M.R., Bartlett, N.W., Hussell, T., Openshaw, P., Johnston, S.L., The microbiology of asthma. Nat Rev Microbiol 10 (2012), 459–471.
5. Busse, W.W., Lemanske, R.F. Jr., Gern, J.E., Role of viral respiratory infections in asthma and asthma exacerbations. Lancet 376 (2010), 826–834.
6. Fahy, J.V., Type 2 inflammation in asthma—present in most, absent in many. Nat Rev Immunol 15 (2015), 57–65.
7. Levy, B.D., Noel, P.J., Freemer, M.M., Cloutier, M.M., Georas, S.N., Jarjour, N.N., et al. Future Research Directions in Asthma. An NHLBI Working Group Report. Am J Respir Crit Care Med 192 (2015), 1366–1372.
8. Lambrecht, B.N., Hammad, H., The immunology of asthma. Nat Immunol 16 (2015), 45–56.
9. Umetsu, D.T., DeKruyff, R.H., The regulation of allergy and asthma. Immunol Rev 212 (2006), 238–255.
10. Fajt, M.L., Wenzel, S.E., Asthma phenotypes and the use of biologic medications in asthma and allergic disease: the next steps toward personalized care. J Allergy Clin Immunol 135 (2015), 299–311.
11. Kabesch, M., Schedel, M., Carr, D., Woitsch, B., Fritzsch, C., Weiland, S.K., et al. IL-4/IL-13 pathway genetics strongly influence serum IgE levels and childhood asthma. J Allergy Clin Immunol 117 (2006), 269–274.
12. Moffatt, M.F., Gut, I.G., Demenais, F., Strachan, D.P., Bouzigon, E., Heath, S., et al. A large-scale, consortium-based genomewide association study of asthma. N Engl J Med 363 (2010), 1211–1221.
13. Gauthier, M., Ray, A., Wenzel, S.E., Evolving Concepts of Asthma. Am J Respir Crit Care Med 192 (2015), 660–668.
14. Mamessier, E., Nieves, A., Lorec, A.M., Dupuy, P., Pinot, D., Pinet, C., et al. T-cell activation during exacerbations: a longitudinal study in refractory asthma. Allergy 63 (2008), 1202–1210.
15. Jackson, D.J., Makrinioti, H., Rana, B.M., Shamji, B.W., Trujillo-Torralbo, M.B., Footitt, J., et al. IL-33-dependent type 2 inflammation during rhinovirus-induced asthma exacerbations in vivo. Am J Respir Crit Care Med 190 (2014), 1373–1382.
16. Beale, J., Jayaraman, A., Jackson, D.J., Macintyre, J.D., Edwards, M.R., Walton, R.P., et al. Rhinovirus-induced IL-25 in asthma exacerbation drives type 2 immunity and allergic pulmonary inflammation. Sci Transl Med, 6, 2014, 256ra134.
17. Snelgrove, R.J., Gregory, L.G., Peiro, T., Akthar, S., Campbell, G.A., Walker, S.A., et al. Alternaria-derived serine protease activity drives IL-33-mediated asthma exacerbations. J Allergy Clin Immunol 134 (2014), 583–592.e6.
18. Lambrecht, B.N., Hammad, H., Lung dendritic cells in respiratory viral infection and asthma: from protection to immunopathology. Annu Rev Immunol 30 (2012), 243–270.
19. Swiecki, M., Colonna, M., The multifaceted biology of plasmacytoid dendritic cells. Nat Rev Immunol 15 (2015), 471–485.
20. Merad, M., Sathe, P., Helft, J., Miller, J., Mortha, A., The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting. Annu Rev Immunol 31 (2013), 563–604.
21. Gilliet, M., Cao, W., Liu, Y.J., Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases. Nat Rev Immunol 8 (2008), 594–606.
22. Swiecki, M., Colonna, M., Unraveling the functions of plasmacytoid dendritic cells during viral infections, autoimmunity, and tolerance. Immunol Rev 234 (2010), 142–162.
23. Takagi, H., Fukaya, T., Eizumi, K., Sato, Y., Sato, K., Shibazaki, A., et al. Plasmacytoid dendritic cells are crucial for the initiation of inflammation and T cell immunity in vivo. Immunity 35 (2011), 958–971.
24. Guery, L., Hugues, S., Tolerogenic and activatory plasmacytoid dendritic cells in autoimmunity. Front Immunol, 4, 2013, 59.
25. Karrich, J.J., Jachimowski, L.C., Uittenbogaart, C.H., Blom, B., The plasmacytoid dendritic cell as the Swiss army knife of the immune system: molecular regulation of its multifaceted functions. J Immunol 193 (2014), 5772–5778.
26. Dua, B., Watson, R.M., Gauvreau, G.M., O'Byrne, P.M., Myeloid and plasmacytoid dendritic cells in induced sputum after allergen inhalation in subjects with asthma. J Allergy Clin Immunol 126 (2010), 133–139.
27. Bratke, K., Lommatzsch, M., Julius, P., Kuepper, M., Kleine, H.D., Luttmann, W., et al. Dendritic cell subsets in human bronchoalveolar lavage fluid after segmental allergen challenge. Thorax 62 (2007), 168–175.
28. Tworek, D., Smith, S.G., Salter, B.M., Baatjes, A.J., Scime, T., Watson, R., et al. IL-25 receptor expression on airway dendritic cells after allergen challenge in subjects with asthma. Am J Respir Crit Care Med 193 (2016), 957–964.
29. Xanthou, G., Alissafi, T., Semitekolou, M., Simoes, D.C., Economidou, E., Gaga, M., et al. Osteopontin has a crucial role in allergic airway disease through regulation of dendritic cell subsets. Nat Med 13 (2007), 570–578.
30. de Heer, H.J., Hammad, H., Soullie, T., Hijdra, D., Vos, N., Willart, M.A., et al. Essential role of lung plasmacytoid dendritic cells in preventing asthmatic reactions to harmless inhaled antigen. J Exp Med 200 (2004), 89–98.
31. Kool, M., van Nimwegen, M., Willart, M.A., Muskens, F., Boon, L., Smit, J.J., et al. An anti-inflammatory role for plasmacytoid dendritic cells in allergic airway inflammation. J Immunol 183 (2009), 1074–1082.
32. Koltsida, O., Hausding, M., Stavropoulos, A., Koch, S., Tzelepis, G., Ubel, C., et al. IL-28A (IFN-lambda2) modulates lung DC function to promote Th1 immune skewing and suppress allergic airway disease. EMBO Mol Med 3 (2011), 348–361.
33. Bartlett, N.W., Walton, R.P., Edwards, M.R., Aniscenko, J., Caramori, G., Zhu, J., et al. Mouse models of rhinovirus-induced disease and exacerbation of allergic airway inflammation. Nat Med 14 (2008), 199–204.
34. Kips, J.C., Fahy, J.V., Hargreave, F.E., Ind, P.W., in't Veen, J.C., Methods for sputum induction and analysis of induced sputum: a method for assessing airway inflammation in asthma. Eur Respir J Suppl 26 (1998), 9S–12S.
35. Koltsida, O., Karamnov, S., Pyrillou, K., Vickery, T., Chairakaki, A.D., Tamvakopoulos, C., et al. Toll-like receptor 7 stimulates production of specialized pro-resolving lipid mediators and promotes resolution of airway inflammation. EMBO Mol Med 5 (2013), 762–775.
36. Asselin-Paturel, C., Brizard, G., Pin, J.J., Briere, F., Trinchieri, G., Mouse strain differences in plasmacytoid dendritic cell frequency and function revealed by a novel monoclonal antibody. J Immunol 171 (2003), 6466–6477.
37. Kopecka, J., Rozkova, D., Sediva, A., Plasmacytoid DCs, exposed to TSLP in synergy with TLR ligands, acquire significant potential towards Th2 polarization. Med Sci Monit Basic Res 19 (2013), 291–299.
38. Diehl, S., Chow, C.W., Weiss, L., Palmetshofer, A., Twardzik, T., Rounds, L., et al. Induction of NFATc2 expression by interleukin 6 promotes T helper type 2 differentiation. J Exp Med 196 (2002), 39–49.
39. Diehl, S., Anguita, J., Hoffmeyer, A., Zapton, T., Ihle, J.N., Fikrig, E., et al. Inhibition of Th1 differentiation by IL-6 is mediated by SOCS1. Immunity 13 (2000), 805–815.
40. Ma, D.Y., Clark, E.A., The role of CD40 and CD154/CD40L in dendritic cells. Semin Immunol 21 (2009), 265–272.
41. Camelo, A., Barlow, J.L., Drynan, L.F., Neill, D.R., Ballantyne, S.J., Wong, S.H., et al. Blocking IL-25 signalling protects against gut inflammation in a type-2 model of colitis by suppressing nuocyte and NKT derived IL-13. J Gastroenterol 47 (2012), 1198–1211.
42. Rissoan, M.C., Soumelis, V., Kadowaki, N., Grouard, G., Briere, F., de Waal Malefyt, R., et al. Reciprocal control of T helper cell and dendritic cell differentiation. Science 283 (1999), 1183–1186.
43. Ito, T., Amakawa, R., Inaba, M., Hori, T., Ota, M., Nakamura, K., et al. Plasmacytoid dendritic cells regulate Th cell responses through OX40 ligand and type I IFNs. J Immunol 172 (2004), 4253–4259.
44. Farkas, L., Kvale, E.O., Johansen, F.E., Jahnsen, F.L., Lund-Johansen, F., Plasmacytoid dendritic cells activate allergen-specific TH2 memory cells: modulation by CpG oligodeoxynucleotides. J Allergy Clin Immunol 114 (2004), 436–443.
45. Jenkins, S.J., Perona-Wright, G., Worsley, A.G., Ishii, N., MacDonald, A.S., Dendritic cell expression of OX40 ligand acts as a costimulatory, not polarizing, signal for optimal Th2 priming and memory induction in vivo. J Immunol 179 (2007), 3515–3523.
46. Maazi, H., Akbari, O., Type two innate lymphoid cells: the Janus cells in health and disease. Immunol Rev 278 (2017), 192–206.
47. Xirakia, C., Koltsida, O., Stavropoulos, A., Thanassopoulou, A., Aidinis, V., Sideras, P., et al. Toll-like receptor 7-triggered immune response in the lung mediates acute and long-lasting suppression of experimental asthma. Am J Respir Crit Care Med 181 (2010), 1207–1216.
48. Cella, M., Facchetti, F., Lanzavecchia, A., Colonna, M., Plasmacytoid dendritic cells activated by influenza virus and CD40L drive a potent TH1 polarization. Nat Immunol 1 (2000), 305–310.
49. Kadowaki, N., Antonenko, S., Lau, J.Y., Liu, Y.J., Natural interferon alpha/beta-producing cells link innate and adaptive immunity. J Exp Med 192 (2000), 219–226.
50. Shi, L.L., Song, J., Xiong, P., Cao, P.P., Liao, B., Ma, J., et al. Disease-specific T-helper cell polarizing function of lesional dendritic cells in different types of chronic rhinosinusitis with nasal polyps. Am J Respir Crit Care Med 190 (2014), 628–638.
51. Palomares, O., Ruckert, B., Jartti, T., Kucuksezer, U.C., Puhakka, T., Gomez, E., et al. Induction and maintenance of allergen-specific FOXP3+ Treg cells in human tonsils as potential first-line organs of oral tolerance. J Allergy Clin Immunol 129 (2012), 510–520 e1-e9.
52. Kucuksezer, U.C., Palomares, O., Ruckert, B., Jartti, T., Puhakka, T., Nandy, A., et al. Triggering of specific Toll-like receptors and proinflammatory cytokines breaks allergen-specific T-cell tolerance in human tonsils and peripheral blood. J Allergy Clin Immunol 131 (2013), 875–885.
53. Bartlett, N.W., Walton, R.P., Edwards, M.R., Aniscenko, J., Caramori, G., Zhu, J., et al. Mouse models of rhinovirus-induced disease and exacerbation of allergic airway inflammation. Nat Med 14 (2008), 199–204.
54. Koltsida, O., Hausding, M., Stavropoulos, A., Koch, S., Tzelepis, G., Ubel, C., et al. IL-28A (IFN-lambda2) modulates lung DC function to promote Th1 immune skewing and suppress allergic airway disease. EMBO Mol Med 3 (2011), 348–361.
55. Xirakia, C., Koltsida, O., Stavropoulos, A., Thanassopoulou, A., Aidinis, V., Sideras, P., et al. Toll-like receptor 7-triggered immune response in the lung mediates acute and long-lasting suppression of experimental asthma. Am J Respir Crit Care Med 181 (2010), 1207–1216.
56. Kips, J.C., Fahy, J.V., Hargreave, F.E., Ind, P.W., Methods for sputum induction and analysis of induced sputum: a method for assessing airway inflammation in asthma. Eur Respir J Suppl 26 (1998), 9S–12S.